PT1399186E - Medicamento para o tratamento de tumores e das suas metástases por utilização de uma molécula de ligação contra a sialoproteína óssea - Google Patents

Medicamento para o tratamento de tumores e das suas metástases por utilização de uma molécula de ligação contra a sialoproteína óssea Download PDF

Info

Publication number
PT1399186E
PT1399186E PT02748771T PT02748771T PT1399186E PT 1399186 E PT1399186 E PT 1399186E PT 02748771 T PT02748771 T PT 02748771T PT 02748771 T PT02748771 T PT 02748771T PT 1399186 E PT1399186 E PT 1399186E
Authority
PT
Portugal
Prior art keywords
bsp
bone
antibodies
active substance
tumor
Prior art date
Application number
PT02748771T
Other languages
English (en)
Portuguese (pt)
Inventor
Franz Paul Armbruster
Markus Karmatschek
Werner Franz Nader
Ulf Joerg Forsmann
Mats Paulsson
Martin R Berger
Original Assignee
Armbruster Biotechnology Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armbruster Biotechnology Gmbh filed Critical Armbruster Biotechnology Gmbh
Publication of PT1399186E publication Critical patent/PT1399186E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT02748771T 2001-06-13 2002-06-12 Medicamento para o tratamento de tumores e das suas metástases por utilização de uma molécula de ligação contra a sialoproteína óssea PT1399186E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01114388 2001-06-13
DE10128639 2001-06-15

Publications (1)

Publication Number Publication Date
PT1399186E true PT1399186E (pt) 2010-02-23

Family

ID=26009516

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02748771T PT1399186E (pt) 2001-06-13 2002-06-12 Medicamento para o tratamento de tumores e das suas metástases por utilização de uma molécula de ligação contra a sialoproteína óssea

Country Status (10)

Country Link
US (2) US7825219B2 (cg-RX-API-DMAC7.html)
EP (1) EP1399186B1 (cg-RX-API-DMAC7.html)
JP (1) JP4570355B2 (cg-RX-API-DMAC7.html)
AT (1) ATE448796T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002319223A1 (cg-RX-API-DMAC7.html)
DE (1) DE50214008D1 (cg-RX-API-DMAC7.html)
DK (1) DK1399186T3 (cg-RX-API-DMAC7.html)
ES (1) ES2336770T3 (cg-RX-API-DMAC7.html)
PT (1) PT1399186E (cg-RX-API-DMAC7.html)
WO (1) WO2002100899A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1514929A1 (en) * 2003-09-12 2005-03-16 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Antisense oligonucleotides for prevention of metastasis formation of cancer cells
EP1888631B1 (de) 2005-05-31 2009-09-23 Ralf Jochem Therapeutsche zusammensetzung zur vorbeugung und bekämpfung von knochenmetastasen
WO2007038397A2 (en) * 2005-09-26 2007-04-05 Novartis Ag Molecular markers associated with bone metastasis
MX2011001930A (es) * 2008-08-29 2011-04-21 Symphogen As Metodo para clonar anticuerpos derivados de aves.
WO2016026917A2 (en) * 2014-08-19 2016-02-25 Immundiagnostik Ag Medicament and apparatus for treating chronic kidney disease
US20250084183A1 (en) * 2021-07-20 2025-03-13 William Marsh Rice University Engineered compositions for bone-targeted therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853219A (en) * 1987-08-06 1989-08-01 President And Fellows Of Harvard College Antibodies to angiogenin: immunotherapeutic agents
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
US5340934A (en) * 1989-11-03 1994-08-23 The United States Of Americas As Represented By The Secretary Of Health & Human Services CDNA sequences of human bone matrix proteins
DK0590058T3 (da) * 1991-06-14 2004-03-29 Genentech Inc Humaniseret heregulin-antistof
CA2370018A1 (en) * 1999-04-09 2000-10-19 Larry W. Fisher Complex formed by n-linked glycoproteins (siblings) and factor h

Also Published As

Publication number Publication date
WO2002100899A2 (de) 2002-12-19
JP4570355B2 (ja) 2010-10-27
AU2002319223A1 (en) 2002-12-23
DK1399186T3 (da) 2010-03-29
ATE448796T1 (de) 2009-12-15
US8808691B2 (en) 2014-08-19
WO2002100899A3 (de) 2003-12-18
JP2005506959A (ja) 2005-03-10
US20110091379A1 (en) 2011-04-21
ES2336770T3 (es) 2010-04-16
EP1399186A2 (de) 2004-03-24
DE50214008D1 (de) 2009-12-31
US7825219B2 (en) 2010-11-02
US20050069547A1 (en) 2005-03-31
EP1399186B1 (de) 2009-11-18

Similar Documents

Publication Publication Date Title
ES2646168T3 (es) Anticuerpos monoclonales para el receptor del factor de crecimiento de fibroblastos 2
US8987205B2 (en) Polynucleotides encoding recombinant lubricin molecules and uses thereof
ES2687786T3 (es) Conjugados para administración ósea y procedimiento de uso de estos para dirigir proteínas al hueso
DE69726404T2 (de) Mesothelinantigen, verfahren und testsatz zur targetierung
EA025891B1 (ru) ВАРИАНТЫ, ПРОИСХОДЯЩИЕ ИЗ ActRIIB, И ИХ ПРИМЕНЕНИЕ
JP2012520661A (ja) 抗血管新生融合タンパク質
JPH09510605A (ja) Ｅｇｆレセプターに対する抗体及びその抗腫瘍効果
BR9709350B1 (pt) anticorpo recombinante ou fragmento de anticorpo recombinante, composiÇço farmacÊutica, Ácido nuclÈico, bacteriàfago, cÉlula hospedeira bacteriana ou de levedura, uso de anticorpo ou fragmento de anticorpo recombinante, processo para a produÇço do mesmo, e, kit diagnàstico.
US8808691B2 (en) Method for treating tumors and their metastases
ES2325485T3 (es) Metodos para identificar compuestos para regular la masa o la funcion muscular utilizando receptores del factor liberador de corticotropina.
CN100398551C (zh) 新的血管内皮细胞生长抑制剂同种型
JP2000080100A (ja) 副甲状腺ホルモン関連タンパクに対するヒトモノクローナル抗体
Hao et al. Vaccination with platelet-derived growth factor B kinoids inhibits CCl4-induced hepatic fibrosis in mice
JPH11341988A (ja) セマフォリンｋ１
JP2000506501A (ja) 抗イディオタイプ血管内皮細胞成長因子抗体およびそれらの医薬としての使用
AU2002322762A1 (en) Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
WO2003012045A2 (en) Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
JP4438987B2 (ja) 腫瘍学的目的のための体液中の骨シアロ蛋白（ｂｏｎｅｓｉａｌｏｐｒｏｔｅｉｎ）の測定方法
US6552177B2 (en) EH domain containing genes and proteins
JP2005508870A6 (ja) 腫瘍学的目的のための体液中の骨シアロ蛋白（ｂｏｎｅｓｉａｌｏｐｒｏｔｅｉｎ）の測定方法
CA2783969A1 (en) A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy